Company Number: SC685621

Analysis Date: 2025-07-29 19:50 UTC

Financial Health Assessment Report for A & A BROS LIMITED

---

1. Financial Health Score: F

Explanation:
The company exhibits severe financial distress, indicated by a massive imbalance between current assets and current liabilities. This score reflects critical symptoms of insolvency risk and inability to meet short-term obligations, signaling an urgent need for remedial action.

---

2. Key Vital Signs

Metric	2024 Value	Interpretation
Current Assets	£39	Extremely low liquid assets; insufficient to cover immediate liabilities.
Current Liabilities	£129,267	Very high short-term debts, a major red flag for liquidity problems.
Net Current Assets	-£129,228	Negative working capital; company cannot cover its short-term debts with available assets.
Total Net Assets	-£131,028	Net liabilities exceed assets, indicating balance sheet insolvency.
Share Capital	£1	Minimal capital base, limiting financial resilience.
Employees	0	No staff employed, which may imply either a dormant or non-operational status.

Interpretation:
The "vital signs" of financial health reveal a company in critical condition. The massive current liabilities dwarf the current assets, producing a highly negative net working capital position. The net assets being negative confirms insolvency on a balance sheet basis. This is akin to a patient with dangerously low blood pressure and multiple organ stress signals — immediate care is needed.

---

3. Diagnosis

A & A BROS LIMITED is suffering from acute financial distress. The company’s liabilities far exceed its assets, and it holds negligible cash or liquid resources to meet its debts. The absence of employees suggests the business is either non-operational or severely downsized, impairing its ability to generate revenue and recover.

The financial data indicates the company is effectively insolvent at the balance sheet date. The liability burden is so significant that the company is unable to meet short-term obligations, a classic symptom of financial failure. Without intervention, the prognosis points towards potential insolvency proceedings, such as liquidation.

---

4. Recommendations

Immediate Actions:

• Liquidity Management: Attempt to reduce current liabilities through negotiation with creditors or restructuring terms to avoid enforcement actions.
• Capital Injection: Seek urgent capital injection from shareholders or external investors to restore positive net assets.
• Operational Review: Evaluate if business operations can be resumed or scaled to generate cash flow; if inactive, consider formal closure to limit further financial deterioration.
• Professional Advice: Engage insolvency practitioners or financial advisors immediately to explore rescue options or orderly wind-down.

Strategic Measures:

• Cost Control: Reduce overheads and non-essential expenses aggressively.
• Revenue Generation: If viable, develop a clear plan to restart or boost trading activities, focusing on quick cash inflows.
• Compliance: Ensure all filings and statutory obligations are up to date to avoid penalties and maintain creditor confidence.

---

Medical Analogy Summary

The company exhibits "symptoms of financial shock" with dangerously low "cash flow vital signs" and "negative net worth" akin to a patient with severe organ failure. Without swift and decisive intervention, the "patient" faces a high risk of "financial collapse."

---